Condition: Respiratory Synctial Virus Infections · Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Respiratory syncytial virus (RSV) is the most common respiratory infectious pathogen recognized worldwide that poses serious health risks to infants, and an important cause of hospitalization for severe respiratory infections in infants. Serious respiratory problems such as pneumonia caused by RSV are one of the leading causes of death from respiratory diseases in infants. AK0529 targets the Pre-F (fusion) protein on the surface of the viral envelope. Specifically, it prevents the virus from invading uninfected cells and inhibits the fusion between host cells by inhibiting the fusion of the F (fusion) proteins on the surface of the RSV envelope, thus providing the effects of anti-RSV infection. This is a randomized, double-blind, placebo-controlled, multicenter, phase III clinical study to evaluate the efficacy and safety of AK0529 in hospitalized infants aged 1 to 24 months with RSV infection. Considering the benefits of AK0529 in the population with RSV infection, hospitalized infants with moderate to severe RSV infection were selected as the target population for this study.
This description comes directly from the study's public registry record.
Chao Yu, Master · +86 021-50681677 · chao.yu@arkbiosciences.com
Always discuss trial participation with your own doctor first.
| Beijing Children's Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Children's Hospital, Capital Medical University | Beijing, China | Recruiting |
| First Hospital of Jilin University | Changchun, China | Recruiting |
| Hunan Provincial People's Hospital | Changsha, China | Recruiting |
| West China Second University Hospital, Sichuan University | Chengdu, China | Recruiting |
| Children's Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| Sanya Central Hospital, Hainan Third People's Hospital | Sanya, China | Recruiting |
| Shanghai Children's Hospital, Shanghai Jiao Tong University | Shanghai, China | Recruiting |
| Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
| Shengjing Hospital of China Medical University | Shenyang, China | Recruiting |
| Tianjin Children's Hospital（Longyan） | Tianjin, China | Recruiting |
| Tianjin Children's Hospital（Machang） | Tianjin, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06775405